H.B. Fuller shares hit a new 52-week low despite reporting better-than-expected quarterly earnings and revenue. This price action contradicts analyst Buy ratings and a consensus target of $67.86. Significant insider selling by VP Nathan Weaver contrasts with positive external analyst sentiment. This divergence may indicate internal concerns regarding short-term valuation or future guidance. The stock decline pressures H.B. Fuller's market cap despite operational strength. Such volatility could impact investor confidence and potential strategic financing options.
121 articles
H.B. Fuller shares dropped to a new 52-week low of $48.60 despite reporting better-than-expected quarterly earnings. The decline coincided with significant insider selling by VP Nathan Weaver, contras
H.B. Fuller is set to report Q3 2026 earnings on September 23rd, with analysts forecasting $1.47 EPS and $948.2 million revenue. The stock maintains a Buy consensus with a price target of $67.86 follo
H.B. Fuller Company will release its Q3 2026 financial results after market close on September 23, 2026. An investor conference call and webcast will follow on September 24 to discuss the findings.
H.B. Fuller received a consensus 'Buy' rating from analysts after reporting quarterly earnings of $1.41 EPS against estimates, with revenue growing 5.8% year-over-year.
H.B. Fuller is expanding Gel-Tac™ microsphere adhesive production at its Italian Pianezze facility to enhance supply responsiveness and reduce carbon footprints. Additionally, the company is developin
H.B. Fuller rejected Ancora Holdings Group's $1.2 billion offer for its Building Adhesives Solutions business, citing undervaluation and operational dis-synergies. The company plans to demonstrate the
H.B. Fuller's board unanimously rejected an unsolicited acquisition proposal from Ancora Holdings Group targeting its Building Adhesives Solutions business. The company reported full-year net sales of
H.B. Fuller rejected a $1.1–1.2 billion offer from activist investor Ancora Group Holdings for its building adhesive solutions unit, citing undervaluation. Ancora reaffirmed its intent to acquire desp
H.B. Fuller's board unanimously rejected an unsolicited acquisition proposal from Ancora for its Building Adhesives Solutions business, citing undervaluation. The company will continue its strategic a
H.B. Fuller rejected Ancora Holdings' $1.2 billion unsolicited offer for its Building Adhesive Solutions business, citing undervaluation. The board remains firm despite Ancora's criticism and potentia
H.B. Fuller rejected Ancora's $1.2 billion offer for its building adhesives unit, citing undervaluation. The activist investor argued the sale would reduce debt and address governance concerns regardi
H.B. Fuller's board has reportedly rejected Ancora's $1.2 billion bid for its building adhesives solutions segment. The decision follows earlier reports that Engine Capital had urged the company to en
H.B. Fuller rejected Ancora Holdings' $1.2 billion bid for its building adhesives unit, citing undervaluation. Shares remained flat as the board deemed the proposal lacked key growth information.
H.B. Fuller director Teresa J. Rasmussen Trangsrud purchased 1,000 shares worth $65,830. The company is also considering a $1.2 billion acquisition proposal.
H.B. Fuller director Teresa J. Rasmussen Trangsrud bought 1,000 shares at $65.83/share on April 17, 2026, raising her holdings to 3,391 shares per amended Form 4 filing.
S&CO Inc. acquired a $14.1 million stake in H.B. Fuller Company, which recently exceeded quarterly earnings expectations with $1.41 EPS and $950.27 million in revenue.
Activist investor Engine Capital is urging H.B. Fuller's board to conduct a market check for its Building Adhesive Solutions segment and the entire company. This move signals a push to explore strateg
H.B. Fuller received an unsolicited $1.1–$1.2 billion cash offer from Ancora Holdings to acquire its Building Adhesives Solutions business. The board will evaluate the proposal with financial and lega
H.B. Fuller has received an unsolicited $1.1–1.2 billion cash offer from Ancora Holdings Group for its Building Adhesives Solutions business. The board will evaluate the proposal with financial advise
H.B. Fuller confirmed an unsolicited cash offer from Ancora Holdings to acquire its building adhesives business for $1.1 billion to $1.2 billion. The proposal follows earlier reports of verbal interes
H.B. Fuller Company submitted an SEC Form 144 filing proposing the sale of 9,561 common stock shares acquired through employee options, totaling approximately $593,332.
Heather Campe, Senior VP of International Growth at H.B. Fuller, received 40,280 phantom units valued at $55.30 per unit on July 31, 2026.
Sei Investments Co. increased its stake in H.B. Fuller by 19.2% to $11.6 million, following strong quarterly earnings and a Moderate Buy rating from analysts.
This article details key metrics for H.B. Fuller Company's bond HBFL5059230, including coupon rates and maturity dates. It also outlines the company's business segments focusing on hygiene, health, an
H.B. Fuller (NYSE: FUL) will go ex-dividend on July 30, 2026, paying $0.245 per share. This announcement marks a key investor event for the specialty chemicals firm.
H.B. Fuller Company reported €3.00 billion in total revenue last year, with the Hygiene, Health and Consumable Adhesives segment leading performance. The United States was the top regional contributor
H.B. Fuller Company reported regional revenue shares as of April 6, 2026, with the Americas leading at 50.33% and EIMEA at 30.22%, though segment data remains undisclosed.
H.B. Fuller Company (FUL) shares traded at $55.78, down 1.33%. As a pure-play adhesives firm, it manufactures specialty chemical products for hygiene, health, engineering, and construction segments.
H.B. Fuller secured new Term A loans and expanded credit capacity while extending maturities to 2031. The board declared a quarterly dividend of $0.2450 per share to improve liquidity.
H.B. Fuller Company shares rose 0.96% to $55.70, maintaining healthy fundamentals and a 1.69% dividend yield. Analysts retain a Buy rating with a $73.91 target, indicating 34% upside potential.
ChemBrief